Citadel Advisors
CHE icon

Citadel Advisors’s Chemed CHE Stock Holding History

Citadel Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793K Sell
2,100
-500
-19% -$214K ﹤0.01% 8207
2025
Q4 		$1.11M Buy
2,600
+800
+44% +$348K ﹤0.01% 7163
2025
Q3 		$806K Buy
+1,800
New +$815K ﹤0.01% 8016

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Citadel Advisors's CHE Position: Q1 2026 in Review

Citadel Advisors increased its Chemed (CHE) stake by 518% in Q1 2026, buying an estimated $41M and bringing the position to 114,119 shares worth $43.1M. The position accounts for 0.01% of the portfolio, ranked #1506.

Citadel Advisors first reported a position in CHE in Q2 2013 and has held it in 39 quarters since. The position peaked at $65.1M in Q4 2020. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Citadel Advisors held 114,119 shares of Chemed worth $43.1M as of Q1 2026.
  • Citadel Advisors bought 95,661 Chemed shares in Q1 2026, an estimated $41M.
  • Chemed made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1506 holding.
  • Citadel Advisors first reported a position in Chemed in Q2 2013 and has held it in 39 quarters since.
  • Citadel Advisors's Chemed position peaked at $65.1M in Q4 2020.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.